By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Clovis Oncology 

1871 Folsom Street

Boulder  Colorado  80302  U.S.A.
Phone: n/a Fax: n/a


Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado.


April 20, 2009


Founders: Patrick Mahaffy, and Erle Mast

CEO and Co-founder: Patrick Mahaffy

CMO (Medical): Lindsey Rolfe


Please click here for Clovis Oncology job opportunities.


Please click here for clinical trial information.


All Products

Key Statistics

Ownership: Public

Web Site: Clovis Oncology
Symbol: CLVS

Company News
Myriad Genetics (MYGN) And Clovis Oncology (CLVS) Sign Agreement For Use Of FDA-Approved Bracanalysis Cdx® Test To Identify Patients With Germline BRCA Mutations For Rubraca (Rucaparib) Treatment 4/27/2017 8:18:40 AM
Clovis Oncology (CLVS) To Announce First Quarter 2017 Financial Results And Host Webcast Conference Call On May 3 4/20/2017 10:37:54 AM
Clovis Oncology (CLVS) Announces Data Presentations At AACR Annual Meeting 2017 3/29/2017 7:07:57 AM
Clovis Oncology (CLVS) Presents New Data From Phase II Studies Of Rucaparib In Advanced Ovarian Cancer At 2017 SGO Annual Meeting On Women’s Cancer 3/13/2017 6:28:37 AM
Clovis Oncology (CLVS) Announces 2016 Operating Results 2/23/2017 7:15:51 AM
Clovis Oncology (CLVS) To Announce Fourth Quarter/Year-End 2016 Financial Results And Host Webcast Conference Call On February 22 2/10/2017 6:40:21 AM
Clovis Oncology (CLVS) And Strata Oncology Announce Collaboration To Accelerate Enrollment In Rucaparib Prostate Cancer Development Program 2/1/2017 7:12:07 AM
Clovis Oncology (CLVS) Announces Exercise In Full Of Underwriters' Option To Purchase Additional Shares Of Common Stock 1/5/2017 11:18:03 AM
Clovis Oncology (CLVS) Announces Upsizing And Pricing Of Public Offering Of Common Stock 1/4/2017 9:53:37 AM
Clovis Oncology (CLVS) Announces Proposed Offering Of Common Stock 1/3/2017 9:27:40 AM